State of New Jersey Common Pension Fund D - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 31 filers reported holding XENON PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
State of New Jersey Common Pension Fund D ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,893,861
-22.5%
48,573
-14.4%
0.01%
+14.3%
Q1 2024$2,443,088
-25.3%
56,750
-20.1%
0.01%
-36.4%
Q4 2023$3,270,859
+48.6%
71,013
+10.2%
0.01%
+37.5%
Q3 2023$2,201,749
-11.3%
64,4540.0%0.01%0.0%
Q2 2023$2,481,479
+7.6%
64,4540.0%0.01%0.0%
Q1 2023$2,306,809
-9.2%
64,4540.0%0.01%
-20.0%
Q4 2022$2,541,421
+9.2%
64,4540.0%0.01%
+11.1%
Q3 2022$2,327,000
+52.2%
64,454
-58.4%
0.01%
+50.0%
Q2 2019$1,529,000
-3.0%
155,1000.0%0.01%0.0%
Q1 2019$1,576,000
+61.0%
155,1000.0%0.01%
+50.0%
Q4 2018$979,000
-52.2%
155,1000.0%0.00%
-50.0%
Q3 2018$2,047,000
+43.4%
155,1000.0%0.01%
+60.0%
Q2 2018$1,427,000
+347.3%
155,100
+138.6%
0.01%
+400.0%
Q1 2018$319,000
+73.4%
65,0000.0%0.00%0.0%
Q4 2017$184,000
-4.2%
65,0000.0%0.00%0.0%
Q3 2017$192,000
-6.3%
65,0000.0%0.00%0.0%
Q2 2017$205,000
-21.2%
65,0000.0%0.00%0.0%
Q1 2017$260,000
-48.1%
65,0000.0%0.00%
-50.0%
Q4 2016$501,000
-4.9%
65,0000.0%0.00%0.0%
Q3 2016$527,000
+36.9%
65,0000.0%0.00%0.0%
Q2 2016$385,000
-15.2%
65,0000.0%0.00%0.0%
Q1 2016$454,000
-56.6%
65,000
-50.0%
0.00%0.0%
Q4 2015$1,046,000
+94.8%
130,000
+100.0%
0.00%0.0%
Q3 2015$537,000
-28.3%
65,0000.0%0.00%
-33.3%
Q2 2015$749,00065,0000.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
BVF INC/IL 3,516,851$44,101,0002.72%
Parkman Healthcare Partners LLC 590,267$7,402,0002.08%
ACUTA CAPITAL PARTNERS, LLC 517,500$6,489,0001.88%
Soleus Capital Management, L.P. 250,897$3,146,0001.79%
DAFNA Capital Management LLC 346,535$4,346,0001.25%
KNOTT DAVID M 169,000$2,119,0001.16%
Ghost Tree Capital, LLC 325,000$4,076,0001.08%
Avoro Capital Advisors LLC 2,800,000$35,112,0000.69%
NEA Management Company, LLC 992,107$12,441,0000.50%
Orbimed Advisors 2,497,917$31,324,0000.44%
View complete list of XENON PHARMACEUTICALS INC shareholders